Literature DB >> 19930784

Aspiration and development of subglottic stenosis in patients with Wegener's granulomatosis.

A C Church1, K Goldsmith, P Sivasothy.   

Abstract

OBJECTIVE: In patients with Wegener's granulomatosis, subglottic stenosis can develop due to active disease; however, some patients develop subglottic stenosis with no clear evidence of airway inflammation. In some cases of idiopathic subglottic stenosis, an association with gastroesophageal reflux disease has been found. Our study assessed the potential role of gastroesophageal reflux as an aetiological factor in the development of subglottic stenosis in patients with Wegener's granulomatosis.
DESIGN: We assessed evidence of active reflux disease, using 24-hour pH monitoring and assessment of bile salts in bronchoalveolar lavage fluid.
SUBJECTS: Ten Wegener's granulomatosis patients with subglottic stenosis underwent 24-hour pH monitoring and bronchoscopy and lavage of the right middle lobe. A similar number of control patients were included.
RESULTS: There was no statistically significant difference in the occurrence of bronchoalveolar bile salts in patients with subglottic stenosis (n = 2) versus control patients (zero) (p = 0.457). There was good correlation between the detection of reflux by 24-hour pH monitoring and the detection of bronchoalveolar bile salts (kappa = 0.769).
CONCLUSION: In this small study of patients with Wegener's granulomatosis, there was no evidence of an association between the development of subglottic stenosis and gastroesophageal reflux.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19930784     DOI: 10.1017/S0022215109991952

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Treatment for adult idiopathic and Wegener-associated subglottic stenosis.

Authors:  Haralampos Gouveris; Niki Karaiskaki; Dimitrios Koutsimpelas; Cheerasook Chongolwatana; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-07       Impact factor: 2.503

2.  Biomarkers for gastroesophageal reflux in respiratory diseases.

Authors:  Ossur Ingi Emilsson; Thornórarinn Gíslason; Anna-Carin Olin; Christer Janson; Isleifur Olafsson
Journal:  Gastroenterol Res Pract       Date:  2013-04-09       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.